This Finnish company (Hall B, #7142) is developing a full-field digital mammography system that it plans to offer as a retrofit to its installed base of Sophie screening units. Sophie Digital uses charge-coupled device (CCD) technology and a
This Finnish company (Hall B, #7142) is developing a full-field digital mammography system that it plans to offer as a retrofit to its installed base of Sophie screening units. Sophie Digital uses charge-coupled device (CCD) technology and a slot-scanning architecture, with resolution of 17 line pairs/mm and a field-of-view of 24 x 30 cm. Planmed hopes to start clinical trials of the system next year in preparation for a regulatory submission to the FDA.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.